AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
MetLife’s shares rose 1.11% on August 4, with a trading volume of $280 million, ranking 390th in daily activity. The insurer is set to report Q2 2025 earnings on August 6, with analyst estimates forecasting $2.19 per share on $18.4 billion in revenue, reflecting year-over-year declines of 4% and 1.5%, respectively. For the full year, revenue is projected to rise 2.4% to $74.8 billion, while EPS is expected to jump 10.5% to $8.96.
Analysts highlight potential tailwinds for the quarter, including a 2.9% year-over-year increase in adjusted group benefits and improved performance in Asia and Latin America. Stronger underwriting results and higher variable investment income in Asia, alongside growth in Latin America’s adjusted earnings, are seen as key drivers. However, rising operational costs and a 1.4% decline in net investment income to $5.1 billion may temper profit growth. MetLife’s Zacks ESP score of +0.67% and a Sell rank (#4) suggest a lower likelihood of outperforming estimates.
Strategies focused on high-liquidity stocks have shown significant outperformance, with a 166.71% return from 2022 to present compared to a 29.18% benchmark. This underscores the impact of trading volume and institutional activity on short-term equity performance, particularly in volatile markets.

Market Watch column provides a thorough analysis of stock market fluctuations and expert ratings.

Dec.31 2025

Dec.31 2025

Dec.30 2025

Dec.30 2025

Dec.29 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet